ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: back pain

Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis

Arthritis & Rheumatology  |  June 27, 2019

Adding certolizumab pegol to background medication is better than adding a placebo for patients with active nonradiographic axial spondyloarthritis, according to a new study…

Filed under:Axial SpondyloarthritisConditionsResearch Rheum Tagged with:Arthritis & Rheumatologyaxial spondyloarthritis (SpA)Certolizumab PegolResearch

Acute Microcrystalline Arthropathy Masquerades as Infectious Discitis

Jessita Albert Messiah Dhas, MD, Erik O’Connell, DO, & Lisa L. Schroeder, MD  |  June 17, 2019

Monosodium urate (MSU) crystal deposition commonly occurs within the distal appendicular skeleton. The peripheral nature of gout is a hallmark feature described in the ACR and the European League Against Rheumatism (EULAR) clinical practice guidelines.1 In this article, we report a rare presentation of a common disease: a case of axial gouty arthropathy masquerading as…

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:DiscitisGoutMicrocrystalline Arthropathy

What Pharmacists Want Rheumatologists to Know

Linda Childers  |  May 18, 2019

Involving pharmacists in the management of chronic diseases benefits patients, says Wendy Ramey, BSPharm, RPh, CSP, a clinical pharmacy specialist in rheumatology at the University of Kentucky, Lexington. She knows this personally. As someone with rheumatoid arthritis (RA), Ms. Ramey knows pharmacists can play an important role in patient education and encouraging adherence to medications….

Filed under:Patient PerspectivePractice Support Tagged with:adherenceAssociation of Rheumatology Professionals (ARP)pharmacistprior authorizationself-injectionvaccination

Shared Decision Making, Good Disease Control Are Key Components of JIA Management

Kelly Tyrrell  |  May 15, 2019

A group led by Sarah Ringold, MD, MS, assistant professor of rheumatology at Seattle Children’s Hospital, has developed a new guideline intended to provide recommendations for the treatment and monitoring of children with juvenile idiopathic arthritis (JIA) manifesting as non-systemic polyarthritis, sacroiliitis or enthesitis.1,2 Key Updates The new recommendations appear in both Arthritis & Rheumatology…

Filed under:Clinical Criteria/Guidelines Tagged with:Enthesitisjuvenile idiopathic arthritis (JIA)polyarthritissacroiliitisSarah Ringold

The Benefits of Blood Money: OxyContin & Ethics

Philip Seo, MD, MHS  |  March 18, 2019

On Feb. 9, 2019, protesters gathered at the Guggenheim Museum in New York City to lead a march down Fifth Avenue to the Metropolitan Museum of Art.1 As a general rule, news from the world of art is not a topic discussed in these pages, but if you indulge me for just a little bit…

Filed under:EthicsOpinionRheuminationsSpeak Out Rheum Tagged with:Arthur M. Sackler FoundationDr. Mortimer and Theresa Sackler Foundationopioid crisisopioid use disordersOxyContinPurdue PharmaRaymond and Beverly Sackler Foundation

Coding Corner Question: Use Level 3 or 4 for RA/Gout Patient?

From the College  |  March 11, 2019

A 60-year-old man returns for a follow-up related to his diagnoses of rheumatoid arthritis and chronic gout of his right ankle and foot, without tophi. He reports the gout flares have subsided in his ankle. He takes 450 mg of allopurinol daily. He has rheumatoid factor-positive rheumatoid arthritis, which previously affected multiple sites, without organ…

Filed under:Billing/CodingConditionsFrom the CollegeGout and Crystalline ArthritisRheumatoid Arthritis Tagged with:Current Procedural Terminology (CPT) codesGout

Safety Risk with Higher Dose Tofacitnib

Michele B. Kaufman, PharmD, BCGP  |  March 6, 2019

According to the FDA, an ongoing safety trial found higher dose tofacitinib increased the risks of pulmonary embolism and death in RA patients…

Filed under:Drug Updates Tagged with:cardiovasculardeathDrug SafetyFood and Drug Administrationpulmonary embolismsafety warningTofacitinibU.S. Food and Drug Administration (FDA)

2 Medical Schools Work to Improve Rheumatology Learning

Thomas R. Collins  |  February 18, 2019

CHICAGO—The pre-clinical rheumatology curriculum at the University of North Carolina (UNC) School of Medicine, Chapel Hill, used to consist mainly of portions of a musculoskeletal course, with up to only three instructional hours, and not always with a rheumatologist in the room with students. Systemic autoimmune diseases were never fully discussed in any of the…

Filed under:Education & TrainingMeeting ReportsProfessional Topics Tagged with:2018 ACR/ARHP Annual Meetingcurriculummedical school

The 2018 ARHP Merit Awards & ACR Distinguished Fellows

Carol Patton, with Keri Losavio  |  December 18, 2018

CHICAGO—At the 2018 ACR/ARHP Annual Meeting in October, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARHP Merit Awards about their individual contributions to advancing rheumatology. You’ll also find interviews…

Filed under:AwardsMeeting Reports Tagged with:2018 ACR/ARHP Annual MeetingAssociation of Rheumatology Professionals (ARP)Daniel SchafferDanielle RiceDr. Ann Marie SzymanskiDr. Antonia ValenzuelaDr. April M. JorgeDr. Bella MehtaDr. Brittany AdlerDr. Carol A. OatisDr. Charles G. HelmickDr. Christina H. OpavaDr. DeAnna A. Baker FrostDr. Debbie Ehrmann-FeldmanDr. Marcela A. FerradaDr. Patrick R. WoodDr. Sara AlehashemiDr. Shudan WangHiral MasterJanalee TaylorLisa Robbins

Annual Meeting Speakers Review Studies Ranging from Opioids to Fibroblasts

Thomas R. Collins  |  December 18, 2018

CHICAGO—Findings on opioid efficacy, serum urate in osteoarthritis and arthrocentesis headlined the top research of the year discussed in the first half of a session at the 2018 ACR/ARHP Annual Meeting. The second half covered basic science findings, including summaries of new insights into the gender bias in autoimmune diseases, platelet microparticles in scleroderma and…

Filed under:Meeting ReportsResearch Rheum Tagged with:2018 ACR/ARHP Annual MeetingarthrocentesisfibroblastsGenderopioid efficacyOsteoarthritisRheumatoid Arthritis (RA)Scleroderma

  • « Previous Page
  • 1
  • …
  • 26
  • 27
  • 28
  • 29
  • 30
  • …
  • 164
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences